X-linked lymphoproliferative syndrome: A genetic condition typified by the triad of infection, immunodeficiency and lymphoma

British Journal of Haematology

Volumn 152, Issue 1, 2011, Pages 13-30

  Rezaei, Nima ^a,b,c   Mahmoudi, Elham ^b   Aghamohammadi, Asghar ^b   Das, Rupali ^d   Nichols, Kim E ^d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Immunodeficiency; Infection; Malignancy; SLAM associated protein; X linked lymphoproliferative syndrome

Indexed keywords

CYTOCHROME P450 2B4; GAMMA INTERFERON; INTERLEUKIN 4; PROTEIN NTB A; RITUXIMAB; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

APLASTIC ANEMIA; CD8+ T LYMPHOCYTE; CLINICAL FEATURE; CYTOKINE PRODUCTION; CYTOTOXICITY; DISEASE PREDISPOSITION; DYSGAMMAGLOBULINEMIA; EPSTEIN BARR VIRUS INFECTION; GENE EXPRESSION; GENE FUNCTION; GENE INTERACTION; GENE LOCUS; GENE LOSS; GENE MUTATION; GENETIC PREDISPOSITION; GERMINAL CENTER; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HETEROZYGOSITY; HUMAN; IMMUNOPATHOLOGY; INFECTION RISK; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; NATURAL KILLER CELL; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; REVIEW; SIGNAL TRANSDUCTION; VASCULITIS; X CHROMOSOME LINKED DISORDER; X CHROMOSOME LINKED LYMPHOPROLIFERATIVE SYNDROME;

EPSTEIN-BARR VIRUS INFECTIONS; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOMA, NON-HODGKIN; LYMPHOPROLIFERATIVE DISORDERS; OPPORTUNISTIC INFECTIONS;

EID: 78650000871     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08442.x     Document Type: Review

References (184)

1. Aghamohammadi, A., Kanegane, H., Moein, M., Farhoudi, A., Pourpak, Z., Movahedi, M., Gharagozlou, M., Zargar, A.A. & Miyawaki, T. (2003) Identification of an SH2D1A mutation in a hypogammaglobulinemic male patient with a diagnosis of common variable immunodeficiency. International Journal of Hematology, 78, 45-47.
2. Amrolia, P., Gaspar, H.B., Hassan, A., Webb, D., Jones, A., Sturt, N., Mieli-Vergani, G., Pagliuca, A., Mufti, G., Hadzic, N., Davies, G. & Veys, P. (2000) Nonmyeloablative stem cell transplantation for congenital immunodeficiencies. Blood, 96, 1239-1246.
3. Assarsson, E., Kambayashi, T., Schatzle, J.D., Cramer, S.O., Von Bonin, A., Jensen, P.E., Ljunggren, H.G. & Chambers, B.J. (2004) NK cells stimulate proliferation of T and NK cells through 2B4/CD48 interactions. Journal of Immunology, 173, 174-180.
4. Atherly, L.O., Lucas, J.A., Felices, M., Yin, C.C., Reiner, S.L. & Berg, L.J. (2006) The Tec family tyrosine kinases Itk and Rlk regulate the development of conventional CD8+ T cells. Immunity, 25, 79-91.
5. Aversa, G., Chang, C.C., Carballido, J.M., Cocks, B.G. & De Vries, J.E. (1997) Engagement of the signaling lymphocytic activation molecule (SLAM) on activated T cells results in IL-2-independent, cyclosporin A-sensitive T cell proliferation and IFN-gamma production. Journal of Immunology, 158, 4036-4044.
6. Babcock, G.J., Decker, L.L., Volk, M. & Thorley-Lawson, D.A. (1998) EBV persistence in memory B cells in vivo. Immunity, 9, 395-404.
7. Balamuth, N.J., Nichols, K.E., Paessler, M. & Teachey, D.T. (2007) Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis. Journal of Pediatric Hematology/oncology, 29, 569-573.
8. Bar, R.S., DeLor, C.J., Clausen, K.P., Hurtubise, P., Henle, W. & Hewetson, J.F. (1974) Fatal infectious mononucleosis in a family. New England Journal of Medicine, 290, 363-367.
9. Bauler, L.D., Duckett, C.S. & O'Riordan, M.X. (2008) XIAP regulates cytosol-specific innate immunity to Listeria infection. PLoS Pathogens, 4, e1000142.
10. Benoit, L., Wang, X., Pabst, H.F., Dutz, J. & Tan, R. (2000) Defective NK cell activation in X-linked lymphoproliferative disease. Journal of Immunology, 165, 3549-3553.
11. Berzofsky, J.A. & Terabe, M. (2009) The contrasting roles of NKT cells in tumor immunity. Current Molecular Medicine, 9, 667-672.
12. Blaese, R.M. (2007) What is the status of gene therapy for primary immunodeficiency? Immunologic Research, 38, 274-284.
13. Bleharski, J.R., Niazi, K.R., Sieling, P.A., Cheng, G. & Modlin, R.L. (2001) Signaling lymphocytic activation molecule is expressed on CD40 ligand-activated dendritic cells and directly augments production of inflammatory cytokines. Journal of Immunology, 167, 3174-3181.
14. Bloch-Queyrat, C., Fondaneche, M.C., Chen, R., Yin, L., Relouzat, F., Veillette, A., Fischer, A. & Latour, S. (2005) Regulation of natural cytotoxicity by the adaptor SAP and the Src-related kinase Fyn. Journal of Experimental Medicine, 202, 181-192.
15. Booth, C., Gilmour, K.C., Veys, P., Gennery, A.R., Slatter, M.A., Chapel, H., Heath, P.T., Steward, C.G., Smith, O., O'Meara, A., Kerrigan, H., Mahlaoui, N., Cavazzana-Calvo, M., Fischer, A., Moshous, D., Blanche, S., Pachlopnik-Schmid, J., Latour, S., De Saint-Basile, G., Albert, M., Notheis, G., Rieber, N., Strahm, B., Ritterbusch, H., Lankester, A., Hartwig, N.G., Meyts, I., Plebani, A., Soresina, A., Finocchi, A., Pignata, C., Cirillo, E., Bonanomi, S., Peters, C., Kalwak, K., Pasic, S., Sedlacek, P., Jazbec, J., Kanegane, H., Nichols, K.E., Hanson, I.C., Kapoor, N., Haddad, E., Cowan, M., Choo, S., Smart, J., Arkwright, P.D. & Gaspar, H.B. (2010) X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management, and outcome of the disease. Blood, DOI:
16. Bottino, C., Falco, M., Parolini, S., Marcenaro, E., Augugliaro, R., Sivori, S., Landi, E., Biassoni, R., Notarangelo, L.D., Moretta, L. & Moretta, A. (2001) NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. Journal of Experimental Medicine, 194, 235-246.
17. Bouchon, A., Cella, M., Grierson, H.L., Cohen, J.I. & Colonna, M. (2001) Activation of NK cell-mediated cytotoxicity by a SAP-independent receptor of the CD2 family. Journal of Immunology, 167, 5517-5521.
18. Brandau, O., Schuster, V., Weiss, M., Hellebrand, H., Fink, F.M., Kreczy, A., Friedrich, W., Strahm, B., Niemeyer, C., Belohradsky, B.H. & Meindl, A. (1999) Epstein-Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP). Human Molecular Genetics, 8, 2407-2413.
19. Broussard, C., Fleischacker, C., Horai, R., Chetana, M., Venegas, A.M., Sharp, L.L., Hedrick, S.M., Fowlkes, B.J. & Schwartzberg, P.L. (2006) Altered development of CD8+ T cell lineages in mice deficient for the Tec kinases Itk and Rlk. Immunity, 25, 93-104.
20. Brown, M.H., Boles, K., Van Der Merwe, P.A., Kumar, V., Mathew, P.A. & Barclay, A.N. (1998) 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48. Journal of Experimental Medicine, 188, 2083-2090.
21. Cannons, J.L., Yu, L.J., Hill, B., Mijares, L.A., Dombroski, D., Nichols, K.E., Antonellis, A., Koretzky, G.A., Gardner, K. & Schwartzberg, P.L. (2004) SAP regulates T(H)2 differentiation and PKC-theta-mediated activation of NF-kappaB1. Immunity, 21, 693-706.
22. Cannons, J.L., Yu, L.J., Jankovic, D., Crotty, S., Horai, R., Kirby, M., Anderson, S., Cheever, A.W., Sher, A. & Schwartzberg, P.L. (2006) SAP regulates T cell-mediated help for humoral immunity by a mechanism distinct from cytokine regulation. Journal of Experimental Medicine, 203, 1551-1565.
23. Cannons, J.L., Qi, H., Lu, K.T., Dutta, M., Gomez-Rodriguez, J., Cheng, J., Wakeland, E.K., Germain, R.N. & Schwartzberg, P.L. (2010) Optimal germinal center responses require a multistage T cell:B cell adhesion process involving integrins, SLAM-associated protein, and CD84. Immunity, 32, 253-265.
24. Carballido, J.M., Aversa, G., Kaltoft, K., Cocks, B.G., Punnonen, J., Yssel, H., Thestrup-Pedersen, K. & De Vries, J.E. (1997) Reversal of human allergic T helper 2 responses by engagement of signaling lymphocytic activation molecule. Journal of Immunology, 159, 4316-4321.
25. Castro, A.G., Hauser, T.M., Cocks, B.G., Abrams, J., Zurawski, S., Churakova, T., Zonin, F., Robinson, D., Tangye, S.G., Aversa, G., Nichols, K.E., De Vries, J.E., Lanier, L.L. & O'Garra, A. (1999) Molecular and functional characterization of mouse signaling lymphocytic activation molecule (SLAM): differential expression and responsiveness in Th1 and Th2 cells. Journal of Immunology, 163, 5860-5870.
26. Chan, B., Lanyi, A., Song, H.K., Griesbach, J., Simarro-Grande, M., Poy, F., Howie, D., Sumegi, J., Terhorst, C. & Eck, M.J. (2003) SAP couples Fyn to SLAM immune receptors. Nature Cell Biology, 5, 155-160.
27. Chen, R., Relouzat, F., Roncagalli, R., Aoukaty, A., Tan, R., Latour, S. & Veillette, A. (2004) Molecular dissection of 2B4 signaling: implications for signal transduction by SLAM-related receptors. Molecular and Cellular Biology, 24, 5144-5156.
28. Chen, R., Latour, S., Shi, X. & Veillette, A. (2006) Association between SAP and FynT: inducible SH3 domain-mediated interaction controlled by engagement of the SLAM receptor. Molecular and Cellular Biology, 26, 5559-5568.
29. Chung, B., Aoukaty, A., Dutz, J., Terhorst, C. & Tan, R. (2005) Signaling lymphocytic activation molecule-associated protein controls NKT cell functions. Journal of Immunology, 174, 3153-3157.
30. Cocks, B.G., Chang, C.C., Carballido, J.M., Yssel, H., De Vries, J.E. & Aversa, G. (1995) A novel receptor involved in T-cell activation. Nature, 376, 260-263.
31. Coffey, A.J., Brooksbank, R.A., Brandau, O., Oohashi, T., Howell, G.R., Bye, J.M., Cahn, A.P., Durham, J., Heath, P., Wray, P., Pavitt, R., Wilkinson, J., Leversha, M., Huckle, E., Shaw-Smith, C.J., Dunham, A., Rhodes, S., Schuster, V., Porta, G., Yin, L., Serafini, P., Sylla, B., Zollo, M., Franco, B., Bolino, A., Seri, M., Lanyi, A., Davis, J.R., Webster, D., Harris, A., Lenoir, G., De St Basile, G., Jones, A., Behloradsky, B.H., Achatz, H., Murken, J., Fassler, R., Sumegi, J., Romeo, G., Vaudin, M., Ross, M.T., Meindl, A. & Bentley, D.R. (1998) Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nature Genetics, 20, 129-135.
32. Cohen, J.I. (2000) Epstein-Barr virus infection. New England Journal of Medicine, 343, 481-492.
33. Cohen, J.I., Bollard, C.M., Khanna, R. & Pittaluga, S. (2008) Current understanding of the role of Epstein-Barr virus in lymphomagenesis and therapeutic approaches to EBV-associated lymphomas. Leukaemia & Lymphoma, 49(Suppl 1), 27-34.
34. Cooper, N., Rao, K., Gilmour, K., Hadad, L., Adams, S., Cale, C., Davies, G., Webb, D., Veys, P. & Amrolia, P. (2006) Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis. Blood, 107, 1233-1236.
35. Cooper, N., Rao, K., Goulden, N., Webb, D., Amrolia, P. & Veys, P. (2008) The use of reduced-intensity stem cell transplantation in haemophagocytic lymphohistiocytosis and Langerhans cell histiocytosis. Bone Marrow Transplantation, 42(Suppl 2), S47-S50.
36. Crotty, S., Kersh, E.N., Cannons, J., Schwartzberg, P.L. & Ahmed, R. (2003) SAP is required for generating long-term humoral immunity. Nature, 421, 282-287.
37. Czar, M.J., Kersh, E.N., Mijares, L.A., Lanier, G., Lewis, J., Yap, G., Chen, A., Sher, A., Duckett, C.S., Ahmed, R. & Schwartzberg, P.L. (2001) Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A/DSHP/SAP. Proceedings of the National Academy of Sciences of the United States of America, 98, 7449-7454.
38. Davidson, D., Shi, X., Zhang, S., Wang, H., Nemer, M., Ono, N., Ohno, S., Yanagi, Y. & Veillette, A. (2004) Genetic evidence linking SAP, the X-linked lymphoproliferative gene product, to Src-related kinase FynT in T(H)2 cytokine regulation. Immunity, 21, 707-717.
39. Deveraux, Q.L., Takahashi, R., Salvesen, G.S. & Reed, J.C. (1997) X-linked IAP is a direct inhibitor of cell-death proteases. Nature, 388, 300-304.
40. Dhodapkar, M.V., Geller, M.D., Chang, D.H., Shimizu, K., Fujii, S., Dhodapkar, K.M. & Krasovsky, J. (2003) A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma. Journal of Experimental Medicine, 197, 1667-1676.
41. Diana, J. & Lehuen, A. (2009) NKT cells: friend or foe during viral infections? European Journal of Immunology, 39, 3283-3291.
42. Dong, Z., Cruz-Munoz, M.E., Zhong, M.C., Chen, R., Latour, S. & Veillette, A. (2009) Essential function for SAP family adaptors in the surveillance of hematopoietic cells by natural killer cells. Nature Immunology, 10, 973-980.
43. Dupre, L., Andolfi, G., Tangye, S.G., Clementi, R., Locatelli, F., Arico, M., Aiuti, A. & Roncarolo, M.G. (2005) SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells. Blood, 105, 4383-4389.
44. Dutz, J.P., Benoit, L., Wang, X., Demetrick, D.J., Junker, A., De Sa, D. & Tan, R. (2001) Lymphocytic vasculitis in X-linked lymphoproliferative disease. Blood, 97, 95-100.
45. Eastwood, D., Gilmour, K.C., Nistala, K., Meaney, C., Chapel, H., Sherrell, Z., Webster, A.D., Davies, E.G., Jones, A. & Gaspar, H.B. (2004) Prevalence of SAP gene defects in male patients diagnosed with common variable immunodeficiency. Clinical and Experimental Immunology, 137, 584-588.
46. Ebell, M.H. (2004) Epstein-Barr virus infectious mononucleosis. American Family Physician, 70, 1279-1287.
47. Egeler, R.M., De Kraker, J., Slater, R. & Purtilo, D.T. (1992) Documentation of Burkitt lymphoma with t(8;14) (q24;q32) in X-linked lymphoproliferative disease. Cancer, 70, 683-687.
48. Eissmann, P. & Watzl, C. (2006) Molecular analysis of NTB-A signaling: a role for EAT-2 in NTB-A-mediated activation of human NK cells. Journal of Immunology, 177, 3170-3177.
49. Eissmann, P., Beauchamp, L., Wooters, J., Tilton, J.C., Long, E.O. & Watzl, C. (2005) Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244). Blood, 105, 4722-4729.
50. Epstein, M.A., Achong, B.G. & Barr, Y.M. (1964) Virus Particles in Cultured Lymphoblasts from Burkitt's Lymphoma. Lancet, 1, 702-703.
51. Falco, M., Marcenaro, E., Romeo, E., Bellora, F., Marras, D., Vely, F., Ferracci, G., Moretta, L., Moretta, A. & Bottino, C. (2004) Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells. European Journal of Immunology, 34, 1663-1672.
52. Felices, M. & Berg, L.J. (2008) The Tec kinases Itk and Rlk regulate NKT cell maturation, cytokine production, and survival. Journal of Immunology, 180, 3007-3018.
53. Filipovich, A.H., Zhang, K., Snow, A.L. & Marsh, R.A. (2010) X-linked lymphoproliferative syndromes: brothers or distant cousins? Blood, DOI:
54. Flaig, R.M., Stark, S. & Watzl, C. (2004) Cutting edge: NTB-A activates NK cells via homophilic interaction. Journal of Immunology, 172, 6524-6527.
55. Fraser, C.C., Howie, D., Morra, M., Qiu, Y., Murphy, C., Shen, Q., Gutierrez-Ramos, J.C., Coyle, A., Kingsbury, G.A. & Terhorst, C. (2002) Identification and characterization of SF2000 and SF2001, two new members of the immune receptor SLAM/CD2 family. Immunogenetics, 53, 843-850.
56. De La Fuente, M.A., Pizcueta, P., Nadal, M., Bosch, J. & Engel, P. (1997) CD84 leukocyte antigen is a new member of the Ig superfamily. Blood, 90, 2398-2405.
57. De La Fuente, M.A., Tovar, V., Villamor, N., Zapater, N., Pizcueta, P., Campo, E., Bosch, J. & Engel, P. (2001) Molecular characterization and expression of a novel human leukocyte cell-surface marker homologous to mouse Ly-9. Blood, 97, 3513-3520.
58. Galli, G., Nuti, S., Tavarini, S., Galli-Stampino, L., De Lalla, C., Casorati, G., Dellabona, P. & Abrignani, S. (2003) CD1d-restricted help to B cells by human invariant natural killer T lymphocytes. Journal of Experimental Medicine, 197, 1051-1057.
59. Galli, G., Pittoni, P., Tonti, E., Malzone, C., Uematsu, Y., Tortoli, M., Maione, D., Volpini, G., Finco, O., Nuti, S., Tavarini, S., Dellabona, P., Rappuoli, R., Casorati, G. & Abrignani, S. (2007) Invariant NKT cells sustain specific B cell responses and memory. Proceedings of the National Academy of Sciences of the United States of America, 104, 3984-3989.
60. Garni-Wagner, B.A., Purohit, A., Mathew, P.A., Bennett, M. & Kumar, V. (1993) A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells. Journal of Immunology, 151, 60-70.
61. Gaspar, H.B., Sharifi, R., Gilmour, K.C. & Thrasher, A.J. (2002) X-linked lymphoproliferative disease: clinical, diagnostic and molecular perspective. British Journal of Haematology, 119, 585-595.
62. Gilmour, K.C., Cranston, T., Jones, A., Davies, E.G., Goldblatt, D., Thrasher, A., Kinnon, C., Nichols, K.E. & Gaspar, H.B. (2000) Diagnosis of X-linked lymphoproliferative disease by analysis of SLAM-associated protein expression. European Journal of Immunology, 30, 1691-1697.
63. Grierson, H.L., Skare, J., Hawk, J., Pauza, M. & Purtilo, D.T. (1991) Immunoglobulin class and subclass deficiencies prior to Epstein-Barr virus infection in males with X-linked lymphoproliferative disease. American Journal of Medical Genetics, 40, 294-297.
64. Griewank, K., Borowski, C., Rietdijk, S., Wang, N., Julien, A., Wei, D.G., Mamchak, A.A., Terhorst, C. & Bendelac, A. (2007) Homotypic interactions mediated by Slamf1 and Slamf6 receptors control NKT cell lineage development. Immunity, 27, 751-762.
65. Grimbacher, B., Warnatz, K. & Peter, H.H. (2003) The immunological synapse for B-cell memory: the role of the ICOS and its ligand for the longevity of humoral immunity. Current Opinion in Allergy and Clinical Immunology, 3, 409-419.
66. Gross, T.G., Filipovich, A.H., Conley, M.E., Pracher, E., Schmiegelow, K., Verdirame, J.D., Vowels, M., Williams, L.L. & Seemayer, T.A. (1996) Cure of X-linked lymphoproliferative disease (XLP) with allogeneic hematopoietic stem cell transplantation (HSCT): report from the XLP registry. Bone Marrow Transplantation, 17, 741-744.
67. Gulubova, M., Manolova, I., Kyurkchiev, D., Julianov, A. & Altunkova, I. (2009) Decrease in intrahepatic CD56+ lymphocytes in gastric and colorectal cancer patients with liver metastases. Apmis, 117, 870-879.
68. Harrington, D.S., Weisenburger, D.D. & Purtilo, D.T. (1987) Malignant lymphoma in the X-linked lymphoproliferative syndrome. Cancer, 59, 1419-1429.
69. Hislop, A.D., Taylor, G.S., Sauce, D. & Rickinson, A.B. (2007) Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annual Review of Immunology, 25, 587-617.
70. Howie, D., Okamoto, S., Rietdijk, S., Clarke, K., Wang, N., Gullo, C., Bruggeman, J.P., Manning, S., Coyle, A.J., Greenfield, E., Kuchroo, V. & Terhorst, C. (2002) The role of SAP in murine CD150 (SLAM)-mediated T-cell proliferation and interferon gamma production. Blood, 100, 2899-2907.
71. Howie, D., Laroux, F.S., Morra, M., Satoskar, A.R., Rosas, L.E., Faubion, W.A., Julien, A., Rietdijk, S., Coyle, A.J., Fraser, C. & Terhorst, C. (2005) Cutting edge: the SLAM family receptor Ly108 controls T cell and neutrophil functions. Journal of Immunology, 174, 5931-5935.
72. Huck, K., Feyen, O., Niehues, T., Ruschendorf, F., Hubner, N., Laws, H.J., Telieps, T., Knapp, S., Wacker, H.H., Meindl, A., Jumaa, H. & Borkhardt, A. (2009) Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation. Journal of Clinical Investigation, 119, 1350-1358.
73. Hugle, B., Suchowerskyj, P., Hellebrand, H., Adler, B., Borte, M., Sack, U., Overberg-Schmidt, U.S., Strnad, N., Otto, J., Meindl, A. & Schuster, V. (2004) Persistent hypogammaglobulinemia following mononucleosis in boys is highly suggestive of X-linked lymphoproliferative disease--report of three cases. Journal of Clinical Immunology, 24, 515-522.
74. Hurt, C. & Tammaro, D. (2007) Diagnostic evaluation of mononucleosis-like illnesses. American Journal of Medicine, 120, 911-e911.
75. Kambayashi, T., Assarsson, E., Chambers, B.J. & Ljunggren, H.G. (2001) Cutting edge: regulation of CD8(+) T cell proliferation by 2B4/CD48 interactions. Journal of Immunology, 167, 6706-6710.
76. Kamperschroer, C., Dibble, J.P., Meents, D.L., Schwartzberg, P.L. & Swain, S.L. (2006) SAP is required for Th cell function and for immunity to influenza. Journal of Immunology, 177, 5317-5327.
77. Kamperschroer, C., Roberts, D.M., Zhang, Y., Weng, N.P. & Swain, S.L. (2008) SAP enables T cells to help B cells by a mechanism distinct from Th cell programming or CD40 ligand regulation. Journal of Immunology, 181, 3994-4003.
78. Kanegane, H., Kanegane, C., Yachie, A., Miyawaki, T. & Tosato, G. (1997) Infectious mononucleosis as a disease of early childhood in Japan caused by primary Epstein-Barr virus infection. Acta Paediatrica Japonica, 39, 166-171.
79. Kruse, M., Meinl, E., Henning, G., Kuhnt, C., Berchtold, S., Berger, T., Schuler, G. & Steinkasserer, A. (2001) Signaling lymphocytic activation molecule is expressed on mature CD83+ dendritic cells and is up-regulated by IL-1 beta. Journal of Immunology, 167, 1989-1995.
80. Lankester, A.C., Visser, L.F., Hartwig, N.G., Bredius, R.G., Gaspar, H.B., Van Der Burg, M., Van Tol, M.J., Gross, T.G. & Egeler, R.M. (2005) Allogeneic stem cell transplantation in X-linked lymphoproliferative disease: two cases in one family and review of the literature. Bone Marrow Transplantation, 36, 99-105.
81. Latchman, Y., McKay, P.F. & Reiser, H. (1998) Identification of the 2B4 molecule as a counter-receptor for CD48. Journal of Immunology, 161, 5809-5812.
82. Latour, S. & Veillette, A. (2003) Molecular and immunological basis of X-linked lymphoproliferative disease. Immunological Reviews, 192, 212-224.
83. Latour, S., Gish, G., Helgason, C.D., Humphries, R.K., Pawson, T. & Veillette, A. (2001) Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product. Nature Immunology, 2, 681-690.
84. Latour, S., Roncagalli, R., Chen, R., Bakinowski, M., Shi, X., Schwartzberg, P.L., Davidson, D. & Veillette, A. (2003) Binding of SAP SH2 domain to FynT SH3 domain reveals a novel mechanism of receptor signaling in immune regulation. Nature Cell Biology, 5, 149-154.
85. Lee, K.M., Bhawan, S., Majima, T., Wei, H., Nishimura, M.I., Yagita, H. & Kumar, V. (2003) Cutting edge: the NK cell receptor 2B4 augments antigen-specific T cell cytotoxicity through CD48 ligation on neighboring T cells. Journal of Immunology, 170, 4881-4885.
86. Lee, K.M., McNerney, M.E., Stepp, S.E., Mathew, P.A., Schatzle, J.D., Bennett, M. & Kumar, V. (2004) 2B4 acts as a non-major histocompatibility complex binding inhibitory receptor on mouse natural killer cells. Journal of Experimental Medicine, 199, 1245-1254.
87. Lee, K.M., Forman, J.P., McNerney, M.E., Stepp, S., Kuppireddi, S., Guzior, D., Latchman, Y.E., Sayegh, M.H., Yagita, H., Park, C.K., Oh, S.B., Wulfing, C., Schatzle, J., Mathew, P.A., Sharpe, A.H. & Kumar, V. (2006a) Requirement of homotypic NK-cell interactions through 2B4(CD244)/CD48 in the generation of NK effector functions. Blood, 107, 3181-3188.
88. Lee, T.L., Law, H.K.W., Chan, G.C.F., Ha, S.Y., Ho, M.H.K., Chan, K.W. & Lau, Y.L. (2006b) Successful treatment of X-linked Lymphoproliferative disease (XLP) with anti-CD20 monoclonal antibody (Rituximab) followed by mismatched unrelated cord blood transplantation. Hong Kong Journal of Pediatrics, 11, 210-214.
89. Lewis, J., Eiben, L.J., Nelson, D.L., Cohen, J.I., Nichols, K.E., Ochs, H.D., Notarangelo, L.D. & Duckett, C.S. (2001) Distinct interactions of the X-linked lymphoproliferative syndrome gene product SAP with cytoplasmic domains of members of the CD2 receptor family. Clinical Immunology, 100, 15-23.
90. Li, C., Chung, B., Tao, J., Iosef, C., Aoukaty, A., Wang, Y., Tan, R. & Li, S.S. (2008) The X-linked lymphoproliferative syndrome gene product SAP regulates B cell function through the FcgammaRIIB receptor. Cellular Signalling, 20, 1960-1967.
91. Liao, X.C. & Littman, D.R. (1995) Altered T cell receptor signaling and disrupted T cell development in mice lacking Itk. Immunity, 3, 757-769.
92. Lim, M.S. & Elenitoba-Johnson, K.S. (2004) The molecular pathology of primary immunodeficiencies. The Journal of Molecular Diagnostics, 6, 59-83.
93. Lindsten, T., Seeley, J.K., Ballow, M., Sakamoto, K., St Onge, S., Yetz, J., Aman, P. & Purtilo, D.T. (1982) Immune deficiency in the X-linked lymphoproliferative syndrome. II. Immunoregulatory T cell defects. Journal of Immunology, 129, 2536-2540.
94. Linterman, M.A., Rigby, R.J., Wong, R.K., Yu, D., Brink, R., Cannons, J.L., Schwartzberg, P.L., Cook, M.C., Walters, G.D. & Vinuesa, C.G. (2009) Follicular helper T cells are required for systemic autoimmunity. Journal of Experimental Medicine, 206, 561-576.
95. Luzuriaga, K. & Sullivan, J.L. (2010) Infectious mononucleosis. New England Journal of Medicine, 362, 1993-2000.
96. Lynch, L., O'Shea, D., Winter, D.C., Geoghegan, J., Doherty, D.G. & O'Farrelly, C. (2009) Invariant NKT cells and CD1d(+) cells amass in human omentum and are depleted in patients with cancer and obesity. European Journal of Immunology, 39, 1893-1901.
97. Ma, C.S., Hare, N.J., Nichols, K.E., Dupre, L., Andolfi, G., Roncarolo, M.G., Adelstein, S., Hodgkin, P.D. & Tangye, S.G. (2005) Impaired humoral immunity in X-linked lymphoproliferative disease is associated with defective IL-10 production by CD4+ T cells. Journal of Clinical Investigation, 115, 1049-1059.
98. Ma, C.S., Pittaluga, S., Avery, D.T., Hare, N.J., Maric, I., Klion, A.D., Nichols, K.E. & Tangye, S.G. (2006) Selective generation of functional somatically mutated IgM+CD27+, but not Ig isotype-switched, memory B cells in X-linked lymphoproliferative disease. Journal of Clinical Investigation, 116, 322-333.
99. Ma, C.S., Nichols, K.E. & Tangye, S.G. (2007) Regulation of cellular and humoral immune responses by the SLAM and SAP families of molecules. Annual Review of Immunology, 25, 337-379.
100. Malbran, A., Belmonte, L., Ruibal-Ares, B., Bare, P., Massud, I., Parodi, C., Felippo, M., Hodinka, R., Haines, K., Nichols, K.E. & De Bracco, M.M. (2004) Loss of circulating CD27+ memory B cells and CCR4+ T cells occurring in association with elevated EBV loads in XLP patients surviving primary EBV infection. Blood, 103, 1625-1631.
101. Marsh, R.A. (2010) XIAP deficiency: a unique primary immunodeficiency best xlassified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease. Blood, 116, 1079-1082.
102. Marsh, R.A., Villanueva, J., Zhang, K., Snow, A.L., Su, H.C., Madden, L., Mody, R., Kitchen, B., Marmer, D., Jordan, M.B., Risma, K.A., Filipovich, A.H. & Bleesing, J.J. (2009a) A rapid flow cytometric screening test for X-linked lymphoproliferative disease due to XIAP deficiency. Cytometry Part B Clinical Cytometry, 76, 334-344.
103. Marsh, R.A., Villanueva, J., Kim, M.O., Zhang, K., Marmer, D., Risma, K.A., Jordan, M.B., Bleesing, J.J. & Filipovich, A.H. (2009b) Patients with X-linked lymphoproliferative disease due to BIRC4 mutation have normal invariant natural killer T-cell populations. Clinical Immunology, 132, 116-123.
104. Martin, M., Romero, X., De La Fuente, M.A., Tovar, V., Zapater, N., Esplugues, E., Pizcueta, P., Bosch, J. & Engel, P. (2001) CD84 functions as a homophilic adhesion molecule and enhances IFN-gamma secretion: adhesion is mediated by Ig-like domain 1. Journal of Immunology, 167, 3668-3676.
105. Mathew, P.A., Garni-Wagner, B.A., Land, K., Takashima, A., Stoneman, E., Bennett, M. & Kumar, V. (1993) Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells. Journal of Immunology, 151, 5328-5337.
106. Mavaddat, N., Mason, D.W., Atkinson, P.D., Evans, E.J., Gilbert, R.J., Stuart, D.I., Fennelly, J.A., Barclay, A.N., Davis, S.J. & Brown, M.H. (2000) Signaling lymphocytic activation molecule (CDw150) is homophilic but self-associates with very low affinity. Journal of Biological Chemistry, 275, 28100-28109.
107. Mehrle, S., Schmidt, J., Buchler, M.W., Watzl, C. & Marten, A. (2008) Enhancement of anti-tumor activity in vitro and in vivo by CD150 and SAP. Molecular Immunology, 45, 796-804.
108. Milone, M.C., Tsai, D.E., Hodinka, R.L., Silverman, L.B., Malbran, A., Wasik, M.A. & Nichols, K.E. (2005) Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell-directed therapy. Blood, 105, 994-996.
109. Mischler, M., Fleming, G.M., Shanley, T.P., Madden, L., Levine, J., Castle, V., Filipovich, A.H. & Cornell, T.T. (2007) Epstein-Barr virus-induced hemophagocytic lymphohistiocytosis and X-linked lymphoproliferative disease: a mimicker of sepsis in the pediatric intensive care unit. Pediatrics, 119, e1212-e1218.
110. Miyawaki, T. (2004) Primary immunodeficiencies inducing EBV-associated severe illnesses. Iranian Journal of Allergy, Asthma, and Immunology, 3, 51-57.
111. Mooney, J.M., Klem, J., Wulfing, C., Mijares, L.A., Schwartzberg, P.L., Bennett, M. & Schatzle, J.D. (2004) The murine NK receptor 2B4 (CD244) exhibits inhibitory function independent of signaling lymphocytic activation molecule-associated protein expression. Journal of Immunology, 173, 3953-3961.
112. Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M.C., Biassoni, R. & Moretta, L. (2001) Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annual Review of Immunology, 19, 197-223.
113. Morra, M., Silander, O., Calpe, S., Choi, M., Oettgen, H., Myers, L., Etzioni, A., Buckley, R. & Terhorst, C. (2001) Alterations of the X-linked lymphoproliferative disease gene SH2D1A in common variable immunodeficiency syndrome. Blood, 98, 1321-1325.
114. Morra, M., Barrington, R.A., Abadia-Molina, A.C., Okamoto, S., Julien, A., Gullo, C., Kalsy, A., Edwards, M.J., Chen, G., Spolski, R., Leonard, W.J., Huber, B.T., Borrow, P., Biron, C.A., Satoskar, A.R., Carroll, M.C. & Terhorst, C. (2005) Defective B cell responses in the absence of SH2D1A. Proceedings of the National Academy of Sciences of the United States of America, 102, 4819-4823.
115. Mroczek, E.C., Weisenburger, D.D., Grierson, H.L., Markin, R. & Purtilo, D.T. (1987) Fatal infectious mononucleosis and virus-associated hemophagocytic syndrome. Archives of Pathology and Laboratory Medicine, 111, 530-535.
116. Nagy, N. & Klein, E. (2010) Deficiency of the proapoptotic SAP function in X-linked lymphoproliferative disease aggravates Epstein-Barr virus (EBV) induced mononucleosis and promotes lymphoma development. Immunology Letters, 130, 13-18.
117. Nagy, N., Cerboni, C., Mattsson, K., Maeda, A., Gogolak, P., Sumegi, J., Lanyi, A., Szekely, L., Carbone, E., Klein, G. & Klein, E. (2000) SH2D1A and SLAM protein expression in human lymphocytes and derived cell lines. International Journal of Cancer, 88, 439-447.
118. Nagy, N., Mattsson, K., Maeda, A., Liu, A., Szekely, L. & Klein, E. (2002) The X-linked lymphoproliferative disease gene product SAP is expressed in activated T and NK cells. Immunology Letters, 82, 141-147.
119. Nagy, N., Matskova, L., Kis, L.L., Hellman, U., Klein, G. & Klein, E. (2009) The proapoptotic function of SAP provides a clue to the clinical picture of X-linked lymphoproliferative disease. Proceedings of the National Academy of Sciences of the United States of America, 106, 11966-11971.
120. Nakajima, H., Cella, M., Langen, H., Friedlein, A. & Colonna, M. (1999) Activating interactions in human NK cell recognition: the role of 2B4-CD48. European Journal of Immunology, 29, 1676-1683.
121. Nakajima, H., Cella, M., Bouchon, A., Grierson, H.L., Lewis, J., Duckett, C.S., Cohen, J.I. & Colonna, M. (2000) Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity. European Journal of Immunology, 30, 3309-3318.
122. Nelson, D.L. & Terhorst, C. (2000) X-linked lymphoproliferative syndrome. Clinical and Experimental Immunology, 122, 291-295.
123. Nichols, K.E., Harkin, D.P., Levitz, S., Krainer, M., Kolquist, K.A., Genovese, C., Bernard, A., Ferguson, M., Zuo, L., Snyder, E., Buckler, A.J., Wise, C., Ashley, J., Lovett, M., Valentine, M.B., Look, A.T., Gerald, W., Housman, D.E. & Haber, D.A. (1998) Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proceedings of the National Academy of Sciences of the United States of America, 95, 13765-13770.
124. Nichols, K.E., Ma, C.S., Cannons, J.L., Schwartzberg, P.L. & Tangye, S.G. (2005a) Molecular and cellular pathogenesis of X-linked lymphoproliferative disease. Immunological Reviews, 203, 180-199.
125. Nichols, K.E., Hom, J., Gong, S.Y., Ganguly, A., Ma, C.S., Cannons, J.L., Tangye, S.G., Schwartzberg, P.L., Koretzky, G.A. & Stein, P.L. (2005b) Regulation of NKT cell development by SAP, the protein defective in XLP. Nature Medicine, 11, 340-345.
126. Nistala, K., Gilmour, K.C., Cranston, T., Davies, E.G., Goldblatt, D., Gaspar, H.B. & Jones, A.M. (2001) X-linked lymphoproliferative disease: three atypical cases. Clinical and Experimental Immunology, 126, 126-130.
127. Nunez-Cruz, S., Yeo, W.C., Rothman, J., Ojha, P., Bassiri, H., Juntilla, M., Davidson, D., Veillette, A., Koretzky, G.A. & Nichols, K.E. (2008) Differential requirement for the SAP-Fyn interaction during NK T cell development and function. Journal of Immunology, 181, 2311-2320.
128. Okano, M., Bashir, R.M., Davis, J.R. & Purtilo, D.T. (1991) Detection of primary Epstein-Barr virus infection in a patient with X-linked lymphoproliferative disease receiving immunoglobulin prophylaxis. American Journal of Hematology, 36, 294-296.
129. Ostrakhovitch, E.A., Wang, Y. & Li, S.S. (2009) SAP binds to CD22 and regulates B cell inhibitory signaling and calcium flux. Cellular Signalling, 21, 540-550.
130. Parolini, S., Bottino, C., Falco, M., Augugliaro, R., Giliani, S., Franceschini, R., Ochs, H.D., Wolf, H., Bonnefoy, J.Y., Biassoni, R., Moretta, L., Notarangelo, L.D. & Moretta, A. (2000) X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. Journal of Experimental Medicine, 192, 337-346.
131. Pasquier, B., Yin, L., Fondaneche, M.C., Relouzat, F., Bloch-Queyrat, C., Lambert, N., Fischer, A., De Saint-Basile, G. & Latour, S. (2005) Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product. Journal of Experimental Medicine, 201, 695-701.
132. Peck, S.R. & Ruley, H.E. (2000) Ly108: a new member of the mouse CD2 family of cell surface proteins. Immunogenetics, 52, 63-72.
133. Piirilä, H., Väliaho, J. & Vihinen, M. (2006) Immunodeficiency mutation databases (IDbases). Human Mutation, 27, 1200-1208.
134. Prakash, H., Albrecht, M., Becker, D., Kuhlmann, T. & Rudel, T. (2010) Deficiency of XIAP leads to sensitization for Chlamydophila pneumoniae pulmonary infection and dysregulation of innate immune response in mice. Journal of Biological Chemistry, 285, 20291-20302.
135. Provisor, A.J., Iacuone, J.J., Chilcote, R.R., Neiburger, R.G. & Crussi, F.G. (1975) Acquired agammaglobulinemia after a life-threatening illness with clinical and laboratory features of infectious mononucleosis in three related male children. New England Journal of Medicine, 293, 62-65.
136. Punnonen, J., Cocks, B.G., Carballido, J.M., Bennett, B., Peterson, D., Aversa, G. & De Vries, J.E. (1997) Soluble and membrane-bound forms of signaling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytes. Journal of Experimental Medicine, 185, 993-1004.
137. Purtilo, D.T., Cassel, C.K., Yang, J.P. & Harper, R. (1975) X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet, 1, 935-940.
138. Purtilo, D.T., Grierson, H.L., Davis, J.R. & Okano, M. (1991) The X-linked lymphoproliferative disease: from autopsy toward cloning the gene 1975-1990. Pediatric Pathology, 11, 685-710.
139. Qi, H., Cannons, J.L., Klauschen, F., Schwartzberg, P.L. & Germain, R.N. (2008) SAP-controlled T-B cell interactions underlie germinal centre formation. Nature, 455, 764-769.
140. Ram, R. & Raanani, P. (2009) The role of myeloid colony-stimulating factors in the treatment of acute lymphoblastic leukemia - more questions than answers? Leukaemia & Lymphoma, 50, 1737-1739.
141. Renukaradhya, G.J., Khan, M.A., Vieira, M., Du, W., Gervay-Hague, J. & Brutkiewicz, R.R. (2008) Type I NKT cells protect (and type II NKT cells suppress) the host's innate antitumor immune response to a B-cell lymphoma. Blood, 111, 5637-5645.
142. Rigaud, S., Fondaneche, M.C., Lambert, N., Pasquier, B., Mateo, V., Soulas, P., Galicier, L., Le Deist, F., Rieux-Laucat, F., Revy, P., Fischer, A., De Saint Basile, G. & Latour, S. (2006) XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature, 444, 110-114.
143. Roda-Navarro, P., Mittelbrunn, M., Ortega, M., Howie, D., Terhorst, C., Sanchez-Madrid, F. & Fernandez-Ruiz, E. (2004) Dynamic redistribution of the activating 2B4/SAP complex at the cytotoxic NK cell immune synapse. Journal of Immunology, 173, 3640-3646.
144. Romero, X., Benitez, D., March, S., Vilella, R., Miralpeix, M. & Engel, P. (2004) Differential expression of SAP and EAT-2-binding leukocyte cell-surface molecules CD84, CD150 (SLAM), CD229 (Ly9) and CD244 (2B4). Tissue Antigens, 64, 132-144.
145. Romero, X., Zapater, N., Calvo, M., Kalko, S.G., De La Fuente, M.A., Tovar, V., Ockeloen, C., Pizcueta, P. & Engel, P. (2005) CD229 (Ly9) lymphocyte cell surface receptor interacts homophilically through its N-terminal domain and relocalizes to the immunological synapse. Journal of Immunology, 174, 7033-7042.
146. Roncagalli, R., Taylor, J.E., Zhang, S., Shi, X., Chen, R., Cruz-Munoz, M.E., Yin, L., Latour, S. & Veillette, A. (2005) Negative regulation of natural killer cell function by EAT-2, a SAP-related adaptor. Nature Immunology, 6, 1002-1010.
147. Rumble, J.M., Oetjen, K.A., Stein, P.L., Schwartzberg, P.L., Moore, B.B. & Duckett, C.S. (2009) Phenotypic differences between mice deficient in XIAP and SAP, two factors targeted in X-linked lymphoproliferative syndrome (XLP). Cellular Immunology, 259, 82-89.
148. Sayos, J., Wu, C., Morra, M., Wang, N., Zhang, X., Allen, D., Van Schaik, S., Notarangelo, L., Geha, R., Roncarolo, M.G., Oettgen, H., De Vries, J.E., Aversa, G. & Terhorst, C. (1998) The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature, 395, 462-469.
149. Sayos, J., Martin, M., Chen, A., Simarro, M., Howie, D., Morra, M., Engel, P. & Terhorst, C. (2001) Cell surface receptors Ly-9 and CD84 recruit the X-linked lymphoproliferative disease gene product SAP. Blood, 97, 3867-3874.
150. Schatzle, J.D., Sheu, S., Stepp, S.E., Mathew, P.A., Bennett, M. & Kumar, V. (1999) Characterization of inhibitory and stimulatory forms of the murine natural killer cell receptor 2B4. Proceedings of the National Academy of Sciences of the United States of America, 96, 3870-3875.
151. Schimmer, A.D., Dalili, S., Batey, R.A. & Riedl, S.J. (2006) Targeting XIAP for the treatment of malignancy. Cell Death and Differentiation, 13, 179-188.
152. Schuster, V. & Kreth, H.W. (2000) X-linked lymphoproliferative disease is caused by deficiency of a novel SH2 domain-containing signal transduction adaptor protein. Immunological Reviews, 178, 21-28.
153. Seemayer, T.A., Gross, T.G., Egeler, R.M., Pirruccello, S.J., Davis, J.R., Kelly, C.M., Okano, M., Lanyi, A. & Sumegi, J. (1995) X-linked lymphoproliferative disease: twenty-five years after the discovery. Pediatric Research, 38, 471-478.
154. Sharifi, R., Sinclair, J.C., Gilmour, K.C., Arkwright, P.D., Kinnon, C., Thrasher, A.J. & Gaspar, H.B. (2004) SAP mediates specific cytotoxic T-cell functions in X-linked lymphoproliferative disease. Blood, 103, 3821-3827.
155. Slatter, M.A., Bhattacharya, A., Abinun, M., Flood, T.J., Cant, A.J. & Gennery, A.R. (2005) Outcome of boost haemopoietic stem cell transplant for decreased donor chimerism or graft dysfunction in primary immunodeficiency. Bone Marrow Transplantation, 35, 683-689.
156. Snow, A.L., Marsh, R.A., Krummey, S.M., Roehrs, P., Young, L.R., Zhang, K., Van Hoff, J., Dhar, D., Nichols, K.E., Filipovich, A.H., Su, H.C., Bleesing, J.J. & Lenardo, M.J. (2009) Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency. Journal of Clinical Investigation, 119, 2976-2989.
157. Song, L., Asgharzadeh, S., Salo, J., Engell, K., Wu, H.W., Sposto, R., Ara, T., Silverman, A.M., DeClerck, Y.A., Seeger, R.C. & Metelitsa, L.S. (2009) Valpha24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages. Journal of Clinical Investigation, 119, 1524-1536.
158. Soresina, A., Lougaris, V., Giliani, S., Cardinale, F., Armenio, L., Cattalini, M., Notarangelo, L.D. & Plebani, A. (2002) Mutations of the X-linked lymphoproliferative disease gene SH2D1A mimicking common variable immunodeficiency. European Journal of Pediatrics, 161, 656-659.
159. Speckmann, C., Rohr, J. & Ehl, S. (2008) Genetic disorders of immune regulation. In: Primary immunodeficiency diseases: definition, diagnosis and management (ed. by N. Rezaei, A. Aghamohammadi & L.D. Notarangelo ), Vol. 1, pp. 167-194. Berlin Heidelberg, Springer-Verlag.
160. Speiser, D.E., Colonna, M., Ayyoub, M., Cella, M., Pittet, M.J., Batard, P., Valmori, D., Guillaume, P., Lienard, D., Cerottini, J.C. & Romero, P. (2001) The activatory receptor 2B4 is expressed in vivo by human CD8+ effector alpha beta T cells. Journal of Immunology, 167, 6165-6170.
161. Stark, S. & Watzl, C. (2006) 2B4 (CD244), NTB-A and CRACC (CS1) stimulate cytotoxicity but no proliferation in human NK cells. International Immunology, 18, 241-247.
162. Stepp, S.E., Schatzle, J.D., Bennett, M., Kumar, V. & Mathew, P.A. (1999) Gene structure of the murine NK cell receptor 2B4: presence of two alternatively spliced isoforms with distinct cytoplasmic domains. European Journal of Immunology, 29, 2392-2399.
163. Strahm, B., Rittweiler, K., Duffner, U., Brandau, O., Orlowska-Volk, M., Karajannis, M.A., Stadt, U., Tiemann, M., Reiter, A., Brandis, M., Meindl, A. & Niemeyer, C.M. (2000) Recurrent B-cell non-Hodgkin's lymphoma in two brothers with X-linked lymphoproliferative disease without evidence for Epstein-Barr virus infection. British Journal Haematology, 108, 377-382.
164. Sumegi, J., Huang, D., Lanyi, A., Davis, J.D., Seemayer, T.A., Maeda, A., Klein, G., Seri, M., Wakiguchi, H., Purtilo, D.T. & Gross, T.G. (2000) Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease. Blood, 96, 3118-3125.
165. Swann, J.B., Uldrich, A.P., Van Dommelen, S., Sharkey, J., Murray, W.K., Godfrey, D.I. & Smyth, M.J. (2009) Type I natural killer T cells suppress tumors caused by p53 loss in mice. Blood, 113, 6382-6385.
166. Tabata, Y., Villanueva, J., Lee, S.M., Zhang, K., Kanegane, H., Miyawaki, T., Sumegi, J. & Filipovich, A.H. (2005) Rapid detection of intracellular SH2D1A protein in cytotoxic lymphocytes from patients with X-linked lymphoproliferative disease and their family members. Blood, 105, 3066-3071.
167. Talaat, K.R., Rothman, J.A., Cohen, J.I., Santi, M., Choi, J.K., Guzman, M., Zimmerman, R., Nallasamy, S., Brucker, A., Quezado, M., Pittaluga, S., Patronas, N.J., Klion, A.D. & Nichols, K.E. (2009) Lymphocytic vasculitis involving the central nervous system occurs in patients with X-linked lymphoproliferative disease in the absence of Epstein-Barr virus infection. Pediatric Blood and Cancer, 53, 1120-1123.
168. Tangye, S.G., Lazetic, S., Woollatt, E., Sutherland, G.R., Lanier, L.L. & Phillips, J.H. (1999) Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. Journal of Immunology, 162, 6981-6985.
169. Tangye, S.G., Phillips, J.H. & Lanier, L.L. (2000a) The CD2-subset of the Ig superfamily of cell surface molecules: receptor-ligand pairs expressed by NK cells and other immune cells. Seminars in Immunology, 12, 149-157.
170. Tangye, S.G., Phillips, J.H., Lanier, L.L. & Nichols, K.E. (2000b) Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome. Journal of Immunology, 165, 2932-2936.
171. Thorley-Lawson, D.A. & Gross, A. (2004) Persistence of the Epstein-Barr virus and the origins of associated lymphomas. New England Journal of Medicine, 350, 1328-1337.
172. Thorley-Lawson, D.A., Schooley, R.T., Bhan, A.K. & Nadler, L.M. (1982) Epstein-Barr virus superinduces a new human B cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts. Cell, 30, 415-425.
173. Trottestam, H., Beutel, K., Meeths, M., Carlsen, N., Heilmann, C., Pasic, S., Webb, D., Hasle, H. & Henter, J.I. (2009) Treatment of the X-linked lymphoproliferative, Griscelli and Chediak-Higashi syndromes by HLH directed therapy. Pediatric Blood and Cancer, 52, 268-272.
174. Vaidya, S.V., Stepp, S.E., McNerney, M.E., Lee, J.K., Bennett, M., Lee, K.M., Stewart, C.L., Kumar, V. & Mathew, P.A. (2005) Targeted disruption of the 2B4 gene in mice reveals an in vivo role of 2B4 (CD244) in the rejection of B16 melanoma cells. Journal of Immunology, 174, 800-807.
175. Valdez, P.A., Wang, H., Seshasayee, D., Van Lookeren Campagne, M., Gurney, A., Lee, W.P. & Grewal, I.S. (2004) NTB-A, a new activating receptor in T cells that regulates autoimmune disease. Journal of Biological Chemistry, 279, 18662-18669.
176. Valiante, N.M. & Trinchieri, G. (1993) Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes. Journal of Experimental Medicine, 178, 1397-1406.
177. Veillette, A., Zhang, S., Shi, X., Dong, Z., Davidson, D. & Zhong, M.C. (2008) SAP expression in T cells, not in B cells, is required for humoral immunity. Proceedings of the National Academy of Sciences of the United States of America, 105, 1273-1278.
178. Veillette, A., Dong, Z., Perez-Quintero, L.A., Zhong, M.C. & Cruz-Munoz, M.E. (2009) Importance and mechanism of 'switch' function of SAP family adapters. Immunological Reviews, 232, 229-239.
179. Vihinen, M. & Notarangelo, L.D. (2008) SH2D1Abase: mutation registry for X-linked lymphoproliferative syndrome (XLP). In: Databases for immunodeficiency-causing mutations, Vol. 2010. IMT Bioinformatics.
180. Wang, N., Satoskar, A., Faubion, W., Howie, D., Okamoto, S., Feske, S., Gullo, C., Clarke, K., Sosa, M.R., Sharpe, A.H. & Terhorst, C. (2004) The cell surface receptor SLAM controls T cell and macrophage functions. Journal of Experimental Medicine, 199, 1255-1264.
181. Warnatz, K., Bossaler, L., Salzer, U., Skrabl-Baumgartner, A., Schwinger, W., Van Der Burg, M., Van Dongen, J.J., Orlowska-Volk, M., Knoth, R., Durandy, A., Draeger, R., Schlesier, M., Peter, H.H. & Grimbacher, B. (2006) Human ICOS deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency. Blood, 107, 3045-3052.
182. Wu, C., Nguyen, K.B., Pien, G.C., Wang, N., Gullo, C., Howie, D., Sosa, M.R., Edwards, M.J., Borrow, P., Satoskar, A.R., Sharpe, A.H., Biron, C.A. & Terhorst, C. (2001) SAP controls T cell responses to virus and terminal differentiation of TH2 cells. Nature Immunology, 2, 410-414.
183. Yuling, H., Ruijing, X., Li, L., Xiang, J., Rui, Z., Yujuan, W., Lijun, Z., Chunxian, D., Xinti, T., Wei, X., Lang, C., Yanping, J., Tao, X., Mengjun, W., Jie, X., Youxin, J. & Jinquan, T. (2009) EBV-induced human CD8+ NKT cells suppress tumorigenesis by EBV-associated malignancies. Cancer Research, 69, 7935-7944.
184. Zhong, M.C. & Veillette, A. (2008) Control of T lymphocyte signaling by Ly108, a signaling lymphocytic activation molecule family receptor implicated in autoimmunity. Journal of Biological Chemistry, 283, 19255-19264.